Incorporating prescription psychostimulants into the continuum of care for people with stimulant use disorder in Canada

Accumulating evidence supports treatment of stimulant use disorder with prescribed psychostimulants, but no pharmacologic treatments for stimulant use disorder are currently approved in Canada. Off-label prescribing of psychostimulants for stimulant use disorder has been implemented on a small scale in certain jurisdictions in Canada. In the context of an unregulated supply of stimulants, implementation of psychostimulant prescribing can be considered by clinicians who provide care to patients with stimulant use disorder to reduce the use of and harms from illegal stimulant use.

Français : https://www.cmaj.ca/content/195/35/E1200